Conrad Sean M, Strauss-Ayali Dalit, Field Ann E, Mack Matthias, Mosser David M
Department of Cell Biology and Molecular Genetics, Rm. 1103 Microbiology Bldg., University of Maryland, College Park, MD 20742, USA.
Infect Immun. 2007 Feb;75(2):653-65. doi: 10.1128/IAI.01314-06. Epub 2006 Nov 6.
Transgenic Leishmania parasites that encode the murine chemokine monocyte chemoattractant protein 1 (MCP-1) were generated. These parasites transcribed MCP-1 mRNA and secreted MCP-1 protein. Infection of BALB/c, C57BL/6, or MCP-1 knockout (KO) mice with these parasites resulted in minimal lesion development with fewer parasites in the infected foot, lymph node, and spleen compared to wild-type-infected mice. In contrast, transgenic parasites caused substantial lesions with relatively high numbers of parasites in CC chemokine receptor 2 (CCR2) KO mice, indicating that the parasites are viable and healthy and that the lack of lesion development is CCR2 dependent. Prior infection of mice with transgenic parasites offered no protection to subsequent wild-type L. major challenge, suggesting that the transgenic parasites are controlled by an early innate immune response. Consistent with innate immunity, flow cytometry of cells from the ears of mice infected with transgenic parasites revealed an increase in the number of CCR2-positive macrophages by day 7 postinfection. The enumeration of transgenic parasites in ear lesions demonstrated a significant reduction in parasite numbers, which coincided with the increased CCR2-positive macrophage migration. CCR2-positive macrophages isolated from ears of mice infected with transgenic parasites contained virtually no parasites. In vitro studies revealed that optimal parasite killing required the recruitment of CCR2-positive macrophages, followed by stimulation with a combination of both MCP-1 and gamma interferon (IFN-gamma). This work suggests that the parasite-derived MCP-1 can recruit a restrictive population of CCR2-positive macrophages into lesions that can be optimally stimulated by MCP-1 and IFN-gamma to efficiently kill Leishmania parasites.
构建了编码鼠趋化因子单核细胞趋化蛋白1(MCP-1)的转基因利什曼原虫寄生虫。这些寄生虫转录MCP-1 mRNA并分泌MCP-1蛋白。用这些寄生虫感染BALB/c、C57BL/6或MCP-1基因敲除(KO)小鼠,与感染野生型寄生虫的小鼠相比,病变发展最小,感染的足部、淋巴结和脾脏中的寄生虫数量更少。相反,转基因寄生虫在CC趋化因子受体2(CCR2)基因敲除小鼠中引起大量病变,寄生虫数量相对较多,这表明寄生虫是活的且健康的,病变发展的缺乏是CCR2依赖性的。用转基因寄生虫预先感染小鼠对随后的野生型硕大利什曼原虫攻击没有保护作用,这表明转基因寄生虫受早期固有免疫反应的控制。与固有免疫一致,对感染转基因寄生虫的小鼠耳部细胞进行流式细胞术分析显示,感染后第7天CCR2阳性巨噬细胞数量增加。对耳部病变中的转基因寄生虫进行计数表明,寄生虫数量显著减少,这与CCR2阳性巨噬细胞迁移增加相吻合。从感染转基因寄生虫的小鼠耳部分离出的CCR2阳性巨噬细胞几乎不含寄生虫。体外研究表明,最佳的寄生虫杀伤需要招募CCR2阳性巨噬细胞,然后用MCP-1和γ干扰素(IFN-γ)联合刺激。这项工作表明,寄生虫衍生的MCP-1可以将CCR2阳性巨噬细胞的限制性群体募集到病变中,这些巨噬细胞可以被MCP-1和IFN-γ最佳刺激,从而有效杀伤利什曼原虫寄生虫。